TBP Antibody, Rabbit, Polyclonal

Catalog Number: NSJ-F49784-0.08ML
Article Name: TBP Antibody, Rabbit, Polyclonal
Biozol Catalog Number: NSJ-F49784-0.08ML
Supplier Catalog Number: F49784-0.08ML
Alternative Catalog Number: NSJ-F49784-0.08ML
Manufacturer: NSJ Bioreagents
Host: Rabbit
Category: Antikörper
Application: ELISA, FACS, IF, IHC, WB
Species Reactivity: Human
Immunogen: A portion of amino acids 210-239 from the human protein was used as the immunogen for this TBP antibody.
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. A distinctive feature of TBP is a long string of glutamines in the N-terminal. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. Mutations that expand the number of CAG repeats encoding this polyglutamine tract, and thus increase the length of the polyglutamine string, are associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease.
Clonality: Polyclonal
UniProt: P20226
Purity: Purified
Form: In 1X PBS, pH 7.4, with 0.09% sodium azide
Antibody Type: Primary Antibody
Application Dilute: Western blot: 1:1000,Immunofluorescence: 1:10-1:50,IHC (Paraffin): 1:50-1:100,Flow Cytometry: 1:10-1:50
Application Notes: Titration of the TBP antibody may be required due to differences in protocols and secondary/substrate sensitivity.